Stablepoint Partners LLC Reduces Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Stablepoint Partners LLC lessened its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.0% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 5,055 shares of the medical equipment provider’s stock after selling 50 shares during the period. Stablepoint Partners LLC’s holdings in Intuitive Surgical were worth $2,639,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of the stock. Berbice Capital Management LLC purchased a new stake in shares of Intuitive Surgical in the 4th quarter valued at about $26,000. Godsey & Gibb Inc. lifted its stake in Intuitive Surgical by 140.0% in the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after buying an additional 35 shares during the last quarter. MidAtlantic Capital Management Inc. acquired a new stake in shares of Intuitive Surgical in the third quarter valued at approximately $33,000. Decker Retirement Planning Inc. purchased a new position in shares of Intuitive Surgical during the fourth quarter worth approximately $36,000. Finally, Capital Performance Advisors LLP acquired a new position in shares of Intuitive Surgical in the 3rd quarter valued at $38,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Analysts Set New Price Targets

ISRG has been the topic of a number of recent research reports. Stifel Nicolaus boosted their target price on Intuitive Surgical from $525.00 to $610.00 and gave the company a “buy” rating in a report on Thursday, December 5th. Leerink Partners raised their target price on shares of Intuitive Surgical from $489.00 to $502.00 in a research note on Thursday, October 17th. The Goldman Sachs Group set a $604.00 price target on shares of Intuitive Surgical in a research note on Friday, October 18th. Piper Sandler reissued an “overweight” rating and set a $670.00 target price (up from $538.00) on shares of Intuitive Surgical in a research note on Friday. Finally, Royal Bank of Canada boosted their price objective on shares of Intuitive Surgical from $525.00 to $555.00 and gave the stock an “outperform” rating in a report on Friday, October 18th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and fifteen have issued a buy rating to the company. According to MarketBeat.com, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and an average price target of $583.83.

Insider Buying and Selling at Intuitive Surgical

In related news, EVP Robert Desantis sold 188 shares of the stock in a transaction on Tuesday, October 29th. The stock was sold at an average price of $506.52, for a total value of $95,225.76. Following the completion of the sale, the executive vice president now directly owns 5,506 shares in the company, valued at approximately $2,788,899.12. This represents a 3.30 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Jamie Samath sold 22,903 shares of the company’s stock in a transaction dated Friday, November 8th. The stock was sold at an average price of $525.00, for a total value of $12,024,075.00. Following the completion of the sale, the insider now directly owns 8,757 shares of the company’s stock, valued at $4,597,425. The trade was a 72.34 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 42,475 shares of company stock worth $22,070,807 in the last quarter. 0.90% of the stock is owned by insiders.

Intuitive Surgical Stock Performance

ISRG opened at $584.05 on Friday. Intuitive Surgical, Inc. has a 1 year low of $364.17 and a 1 year high of $616.00. The company’s 50 day simple moving average is $547.16 and its 200 day simple moving average is $504.35. The stock has a market capitalization of $208.03 billion, a PE ratio of 93.90, a P/E/G ratio of 5.19 and a beta of 1.39.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.